|
Market Closed -
London S.E.
11:35:01 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 66.20 GBX | 0.00% |
|
+1.07% | +0.30% |
| 08-20 | Venture Life starts GBP2.6 million additional share buyback | AN |
| 08-20 | Venture Life Extends Share Buyback Program | MT |
| Market Cap | 80.65M 109M 93.84M 88.29M 151M 10.3B 151M 1.04B 405M 5.28B 409M 401M 17.02B | P/E 2026 * |
-28.8x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 45.95M 62.13M 53.46M 50.3M 85.96M 5.87B 86.19M 594M 231M 3.01B 233M 228M 9.7B | EV / Sales 2026 * |
0.91x | EV / Sales 2027 * | 1.11x |
| Free-Float |
82.69% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| VLG | Delayed | |
Deutsche Boerse AG
| 17V | Delayed | |
|
Börse Stuttgart
| 17V | Delayed |
Last Transcript : Venture Life Group plc
| 25-08-05 | Venture Life : Result of General Meeting | PU |
| 25-07-16 | Venture Life : Notice of General Meeting | PU |
| 25-06-30 | Venture Life : 2025 AGM Results | PU |
| 25-06-06 | Venture Life : 2025 Notice of AGM | PU |
| 24-06-04 | Venture Life : 2024 AGM Results | PU |
| 1 week | +1.07% | ||
| Current month | +1.07% | ||
| 1 month | -5.02% | ||
| 3 months | +1.07% | ||
| 6 months | -3.36% | ||
| Current year | +0.30% |
| 1 week | 65.25 |  | 67 |
| 1 month | 63.26 | | 69.6 |
| Current year | 54 | | 72 |
| 1 year | 52 | | 72 |
| 3 years | 27 | | 72 |
| 5 years | 23 | | 72 |
| 10 years | 20 | | 118 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeremy Randall
CEO | Chief Executive Officer | 62 | 2010-02-28 |
Daniel Wells
DFI | Director of Finance/CFO | 39 | 2021-11-30 |
Peter Jackson
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Randall
BRD | Director/Board Member | 62 | 2005-12-11 |
Carl Dempsey
BRD | Director/Board Member | - | 2018-09-19 |
Daniel Wells
BRD | Director/Board Member | 39 | 2021-12-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/3/26 | Buy | Chairman | 8,105 | 0.0067% | ||
| 6/3/26 | Buy | Chairman | 8,066 | 0.0066% | ||
| 6/3/26 | Buy | Chairman | 48,373 | 0.0397% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +1.07% | +11.26% | +93.28% | 109M | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.84% | +1.09% | +26.91% | +56.43% | 367.85B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.35M 68.08M 58.58M 55.12M 94.19M 6.43B 94.45M 651M 253M 3.3B 256M 250M 10.62B | 54.7M 73.96M 63.64M 59.88M 102M 6.98B 103M 708M 275M 3.58B 278M 272M 11.54B |
| Net income | -3.21M -4.34M -3.74M -3.52M -6.01M -410M -6.03M -41.56M -16.13M -210M -16.31M -15.96M -678M | 5.3M 7.16M 6.16M 5.8M 9.91M 676M 9.93M 68.49M 26.58M 347M 26.88M 26.3M 1.12B |
| Net Debt | -34.7M -46.92M -40.37M -37.99M -64.91M -4.43B -65.09M -449M -174M -2.27B -176M -172M -7.32B | -20.2M -27.31M -23.5M -22.11M -37.79M -2.58B -37.89M -261M -101M -1.32B -103M -100M -4.26B |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | GBX 66.20 | 0.00% | 111,329 |
| 26-09-03 | GBX 66.20 | +0.76% | 227,865 |
| 26-09-02 | GBX 65.70 | 0.00% | 241,319 |
| 26-09-01 | GBX 65.70 | +0.31% | 65,013 |
| 26-08-28 | GBX 65.50 | -0.76% | 116,799 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6620GBP
Average target price
1.500GBP
Spread / Average Target
+126.59%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VLG Stock
Select your edition
All financial news and data tailored to specific country editions
